The historical rank and industry rank for Mirum Pharmaceuticals's Days Inventory or its related term are showing as below:
MIRM'
s Days Inventory Range Over the Past 10 Years
Min: 101.26 Med: 108.16 Max: 290.2
Current: 101.26
During the past 6 years, Mirum Pharmaceuticals's highest Days Inventory was 290.20. The lowest was 101.26. And the median was 108.16.
MIRM's Days Inventory is ranked better than 74.65% of 651
companies
in the Biotechnology industry
Industry Median: 189.69
vs MIRM: 101.26
Mirum Pharmaceuticals's Days Inventory
declined
from Dec. 2022 (126.99) to Dec. 2023 (81.26).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Mirum Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 was 1.12.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mirum Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.32.
Mirum Pharmaceuticals Days Inventory Historical Data
The historical data trend for Mirum Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mirum Pharmaceuticals's Days Inventory
For the Biotechnology subindustry, Mirum Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mirum Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Mirum Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Mirum Pharmaceuticals's Days Inventory falls into.
Mirum Pharmaceuticals Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Mirum Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mirum Pharmaceuticals (NAS:MIRM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Mirum Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mirum Pharmaceuticals's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Mirum Pharmaceuticals Days Inventory Related Terms
Thank you for viewing the detailed overview of Mirum Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Mirum Pharmaceuticals (Mirum Pharmaceuticals) Business Description
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MIRM has been successfully added to your 